MedDataX Logo

Towards an Early Integration of Palliative Care in Oncology

NCT ID: NCT05339945

Last Updated: 2024-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

361 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-02

Study Completion Date

2024-10-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagnosis to death.

As secondary objectives, the study aims:

* to determinate the proportion of patients with an indication for palliative care according to Hui et al., and to describe the adequation of health needs and the services for them;
* to study the association between clinical pathway and the indication of targeted palliative care;
* to study the association between the integration of palliative care service and the adequation of health needs service of patients;
* to study the factors such as the disease, the practice and the care, contribute to the patient's survivor of 1 year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a descriptive, transversal, multicenter study, which will be performed in healthcare facilities in Ile de France area.

Each investigator center will be composed by oncologist / palliative care and support team. 10 centers will participate to the study, enrollement will be perfomed during 6 months targetting 400 patients with advanced cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metastatic Cancer Palliatives Treatments

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 years;
* Diagnosed metastatic cancer;
* Outpatient or inpatient care at a participating site to the study;
* Affiliation to the social security scheme;
* Patient informed and non-opposed to participate to the study.

Exclusion Criteria

* Testicular or choriocarcinoma ovarian cancer;
* Hematology cancer;
* No understanding french language;
* Unable to express if needed his non-opposition opinion, according to physician investigator;
* Visually impaired, hearing impaired or aphasic.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation de France

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marine SAHUT D'IZARN, MD

Role: PRINCIPAL_INVESTIGATOR

Mobile palliative care and support team, Ambroise Paré hospital, APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mobile palliative care and support team, Ambroise Paré hospital, APHP

Boulogne-Billancourt, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016 Dec;17(12):e552-e559. doi: 10.1016/S1470-2045(16)30577-0.

Reference Type BACKGROUND
PMID: 27924753 (View on PubMed)

Sahut d'Izarn M, Vinant P, Bouleuc C, Joffin I, Vincent B, Barth C, Serresse L, Codogno A, Behal F, Ya-de Rauglaudre L, Jacota M, Gassama M, de Stampa M. Healthcare needs of patients with metastatic cancer and impacts of social vulnerability: a multicentric cross-sectional study in France. BMC Palliat Care. 2025 Sep 29;24(1):233. doi: 10.1186/s12904-025-01882-4.

Reference Type DERIVED
PMID: 41024046 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A01007-34

Identifier Type: REGISTRY

Identifier Source: secondary_id

APHP210724

Identifier Type: -

Identifier Source: org_study_id